Profile
Clare R.
Ozawa is currently a Managing Director at Versant Venture Management LLC.
She is also a Director at Inception Sciences, Inc., Inception IBD, Inc., 858 Therapeutics, Inc., Jengu Therapeutics, Inc., Capsida Biotherapeutics, Inc., Stablix, Inc., Kate Therapeutics, Inc., and Contineum Therapeutics, Inc. Previously, Dr. Ozawa served as the Chief Executive Officer at McKinsey & Co., Inc. and Novartis Pharma AG.
She was also an Independent Director at Oyster Point Pharma, Inc. from 2019 to 2023.
Dr. Ozawa completed her undergraduate degree at Stanford University and holds a doctorate from Stanford University School of Medicine.
Clare Ozawa active positions
| Companies | Position | Start |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | - |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Director/Board Member | - |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Director/Board Member | 2014-05-31 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage drug discovery and biotechnology company that develops molecule drugs for novel therapeutics targets in oncology & immunology | Director/Board Member | - |
Jengu Therapeutics, Inc.
Jengu Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Director/Board Member | - |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director/Board Member | - |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Director/Board Member | - |
Kate Therapeutics, Inc.
Kate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops adeno-associated virus based gene therapies | Director/Board Member | - |
Former positions of Clare Ozawa
| Companies | Position | End |
|---|---|---|
| OYSR POIN | Director/Board Member | 2023-01-02 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Clare Ozawa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Commercial Services |
Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Commercial Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage drug discovery and biotechnology company that develops molecule drugs for novel therapeutics targets in oncology & immunology | Health Technology |
Jengu Therapeutics, Inc.
Jengu Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
Kate Therapeutics, Inc.
Kate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops adeno-associated virus based gene therapies | Health Technology |
- Stock Market
- Insiders
- Clare Ozawa
















